StockStory
1 of Wall Street’s Favorite Stock with Promising Prospects and 2 We Find Risky
📊
AI Sentiment
Positive
7/10
- Home
- USNA
as of 12-09-2025 4:00pm EST
$20.06
+$0.65
+3.35%
Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.
Chart Type:
Time Range:
| Founded: | 1992 | Country: | United States |
| Employees: | N/A | City: | SALT LAKE CITY |
| Market Cap: | 362.9M | IPO Year: | 1996 |
| Target Price: | $36.00 | AVG Volume (30 days): | 174.4K |
| Analyst Decision: | Hold | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.90 | EPS Growth: | -68.25 |
| 52 Week Low/High: | $18.48 - $38.84 | Next Earning Date: | 10-22-2025 |
| Revenue: | $912,670,000 | Revenue Growth: | 5.88% |
| Revenue Growth (this year): | 9.87% | Revenue Growth (next year): | -1.91% |
AI-Powered USNA Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated a day ago
AI Recommendation
hold
Model Accuracy: 72.79%
72.79%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of USANA Health Sciences Inc. (USNA)
Winssinger Frederic J
Sell
Director
USNA Nov 10, 2025
Avg Cost/Share
$19.21
Shares
2,000
Total Value
$38,420.00
Owned After
5,986
SEC Form 4
FULLER GILBERT A
Sell
Director
USNA Nov 3, 2025
Avg Cost/Share
$21.48
Shares
1,057
Total Value
$22,704.25
Owned After
0
SEC Form 4
Fleming John Turman
Sell
Director
USNA Oct 31, 2025
Avg Cost/Share
$19.79
Shares
1,750
Total Value
$34,632.50
Owned After
4,565
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Winssinger Frederic J | USNA | Director | Nov 10, 2025 | Sell | $19.21 | 2,000 | $38,420.00 | 5,986 | |
| FULLER GILBERT A | USNA | Director | Nov 3, 2025 | Sell | $21.48 | 1,057 | $22,704.25 | 0 | |
| Fleming John Turman | USNA | Director | Oct 31, 2025 | Sell | $19.79 | 1,750 | $34,632.50 | 4,565 |
Latest USANA Health Sciences Inc. News
USNA Breaking Stock News: Dive into USNA Ticker-Specific Updates for Smart Investing
StockStory
3 Stocks Under $50 We Find Risky
PR Newswire
USANA Extends Partnership with World-Famous Jamaican Bobsled Team to Help Fuel Their Olympic Dreams
📈
AI Sentiment
Highly Positive
9/10
Simply Wall St.
Shareholders in USANA Health Sciences (NYSE:USNA) are in the red if they invested five years ago
📉
AI Sentiment
Negative
3/10
CNW Group
On National "Make-a-Gift Day," Kevin Guest Says the Most Meaningful Gifts Are the Ones Money Can't Buy
📈
AI Sentiment
Highly Positive
8/10
Compare USNA vs Leading Stocks
See how USNA stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "USNA USANA Health Sciences Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.